Appleは本日、Apple WatchとAirPods Pro 2に登場する、ユーザーが睡眠と聴覚の健康をよりよく管理するために役立つ画期的な健康機能を発表しました。

https://www.apple.com/jp/newsroom/2024/09/apple-introduces-groundbreaking-health-features/

their approval of access through the Centralized Zone Data Service.。

https://www.apple.com/jp/legal/intellectual-property/tld/czds-policy/

as appropriate. All changes are reviewed by Afilias’ operations and security teams and submitted to Apple’s and Afilias’ TLD and BESP management for approva...

https://www.apple.com/jp/legal/intellectual-property/tld/dps/

件のタコグラム）がAHS参加者の⼩集団における⼼房細動と⼀致する不規則な⼼拍 リズムを特定する際に、ePatchによるモニタリングと⽐較して許容可能な陽性適中率（PPV）かどうかを検証しました。AHSの 治験責任医師には、本副次研究、それ以降の分析、またFDAへのデータの提出については伝えましたが、AHSの実施...

https://www.apple.com/jp/healthcare/docs/site/Apple_Watch_Arrhythmia_Detection_JP.pdf

and compared with traditional reference audiometry in a clinical validation study that supported Food and Drug Administration (FDA) listing and authorizatio...

https://www.apple.com/jp/health/pdf/Hearing_Health_Features_on_AirPods_Pro_2_October_2024.pdf

069-0135-K_SPEC, REGULATED SUBSTANCES_Sept2018.pages Apple Regulated Substances Specification 069-0135-K This document contains proprietary information of A...

https://www.apple.com/jp/environment/pdf/Apple_Regulated_Substances_Specification_Sept2018.pdf